Adhesive contact media — an update on graft fixation and burn scar management

Burns ◽  
1991 ◽  
Vol 17 (4) ◽  
pp. 313-319 ◽  
Author(s):  
R.B. Davey ◽  
K.A. Wallis ◽  
K. Bowering
Burns ◽  
2015 ◽  
Vol 41 (2) ◽  
pp. 252-256 ◽  
Author(s):  
Francesca Liuzzi ◽  
Sarah Chadwick ◽  
Mamta Shah

2013 ◽  
Vol 8 (6) ◽  
pp. 589-592
Author(s):  
Alan D Widgerow
Keyword(s):  

2018 ◽  
Vol 22 (36) ◽  
pp. 1-162 ◽  
Author(s):  
Naiem Moiemen ◽  
Jonathan Mathers ◽  
Laura Jones ◽  
Jonathan Bishop ◽  
Philip Kinghorn ◽  
...  

Background Eleven million people suffer a fire-related injury worldwide every year, and 71% have significant scarring. Pressure garment therapy (PGT) is a standard part of burn scar management, but there is little evidence of its clinical effectiveness or cost-effectiveness. Objective To identify the barriers to, and the facilitators of, conducting a randomised controlled trial (RCT) of burn scar management with and without PGT and test whether or not such a trial is feasible. Design Web-based surveys, semistructured individual interviews, a pilot RCT including a health economic evaluation and embedded process evaluation. Setting UK NHS burns services. Interviews and the pilot trial were run in seven burns services. Participants Thirty NHS burns services and 245 staff provided survey responses and 15 staff participated in individual interviews. Face-to-face interviews were held with 24 adult patients and 16 parents of paediatric patients who had undergone PGT. The pilot trial recruited 88 participants (57 adults and 31 children) who were at risk of hypertrophic scarring and were considered suitable for scar management therapy. Interviews were held with 34 participants soon after recruitment, with 23 participants at 12 months and with eight staff from six sites at the end of the trial. Interventions The intervention was standard care with pressure garments. The control was standard care comprising scar management techniques involving demonstration and recommendations to undertake massage three or four times per day with moisturiser, silicone treatment, stretching and other exercises. Main outcome measures Feasibility was assessed by eligibility rates, consent rates, retention in allocated arms, adherence with treatment and follow-up and completion of outcome assessments. The outcomes from interview-based studies were core outcome domains and barriers to, and facilitators of, trial participation and delivery. Results NHS burns services treat 2845 patients per annum (1476 paediatric and 1369 adult) and use pressure garments for 6–18 months, costing £2,171,184. The majority of staff perceived a need for a RCT of PGT, but often lacked equipoise around the research question and PGT as a treatment. Strong views about the use of PGT have the potential to influence the conduct of a full-scale RCT. A range of outcome domains was identified as important via the qualitative research: perceptions of appearance, specific scar characteristics, function, pain and itch, broader psychosocial outcomes and treatment burden. The outcome tools evaluated in the pilot trial did not cover all of these domains. The planned 88 participants were recruited: the eligibility rate was 88% [95% confidence interval (CI) 83% to 92%], the consent rate was 47% (95% CI 40% to 55%). Five (6%) participants withdrew, 14 (16%) were lost to follow-up and 8 (9%) crossed over. Adherence was as in clinical practice. Completion of outcomes was high for adult patients but poorer from parents of paediatric patients, particularly for quality of life. Sections on range of movement and willingness to pay were found to be challenging and poorly completed. Limitations The Brisbane Burn Scar Impact Profile appears more suitable in terms of conceptual coverage than the outcome scales that were used in the trial but was not available at the time of the study. Conclusions A definitive RCT of PGT in burn scar management appears feasible. However, staff attitudes to the use of pressure garments may lead to biases, and the provision of training and support to sites and an ongoing assessment of trial processes are required. Future work We recommend that any future trial include an in-depth mixed-methods recruitment investigation and a process evaluation to account for this. Trial registration Current Controlled Trials ISRCTN34483199. Funding This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 22, No. 36. See the NIHR Journals Library website for further project information


Burns ◽  
2020 ◽  
Vol 46 (1) ◽  
pp. 65-74 ◽  
Author(s):  
Andrea C. Issler-Fisher ◽  
Oliver M. Fisher ◽  
Nicola A. Clayton ◽  
Shivani Aggarwala ◽  
Peter A. Haertsch ◽  
...  

Burns ◽  
2006 ◽  
Vol 32 (4) ◽  
pp. 490-498 ◽  
Author(s):  
Donatello Di Mascio ◽  
Fabio Castagnetti ◽  
Francesca Mazzeo ◽  
Edoardo Caleffi ◽  
Cristiano Dominici
Keyword(s):  

Burns ◽  
1987 ◽  
Vol 13 (5) ◽  
pp. 406-410 ◽  
Author(s):  
K. Perkins ◽  
R. Bruce Davey ◽  
K. Wallis

2020 ◽  
Vol 41 (Supplement_1) ◽  
pp. S104-S105
Author(s):  
Liang Qiao

Abstract Introduction Challenging scars are detrimental for the health-related quality of life of the burn patients, increases financial burdens and, moreover, tests the clinician’s ability to treat these scars. Regenerative epithelial suspension can lead to the restoration of wound and repigmentation, which can treat scar and depigmentation diseases.The application of evidence-based practice has been shown to have the potential to improve health outcomes and strengthen health systems by providing more efficient and cost-effective care. We challenged the noncultured regenerative epithelial suspension in 3 burn scars with hyper- or hypo-pigmentation. Methods The cases presented comprise of a superficial burn scar with hyperpigmentation on face of an 18 year old male, a superficial burn scar with hypopigmentation on the thoracic region of 12 year old girl and a challenging to heel burn scar with hyperpigmentation on the right leg of a 20 year old gentleman. The scars were treated with microdermabrasion, then the ratio of about 1:60–1:150 autologous noncultured regenerative epithelial suspension were obtained and sprayed to the wound. The care givers regularly assessed these wounds till healing, including a clinical, a planimetric and photographic records to 3 months. Results A total of 3 patients with superficial scars treated by non-cultured regenerative epithelial suspension technology combined with microdermabrasion showed significant improvement in skin texture and color. Conclusions Our study showed that regenerative epithelial suspension technology combined with microdermabrasion may improve scar. Applicability of Research to Practice The good clinical outcomes documented through these three selected cases support the use of this new promising treatment in our daily practice of superficial scar management.


2019 ◽  
Vol 52 (2) ◽  
pp. 149-158 ◽  
Author(s):  
Andrea C. Issler‐Fisher ◽  
Oliver M. Fisher ◽  
Peter Haertsch ◽  
Zhe Li ◽  
Peter K.M. Maitz

Sign in / Sign up

Export Citation Format

Share Document